Home » Topics » Regulatory

Regulatory
RSS

Nebivolol claimed for oxidative stress-related disorders

Sep. 13, 1996

Lilly reports new treatment for attention deficit/hyperactivity disorder

Sep. 13, 1996

Rhodanines for multiple sclerosis

Sep. 13, 1996

New formulation of selegiline

Sep. 13, 1996

Known antipsychotic claimed for drug dependence

Sep. 13, 1996

Rapamycin in anemia

Sep. 13, 1996

Novel treatment for bone loss

Sep. 13, 1996

U.S. approval for glaucoma medication

Sep. 13, 1996

Seratrodast claimed for the treatment of atopic dermatitis

Sep. 13, 1996

Liarozole claimed for inhibiting calcitriol metabolism

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...